Career Development Program

RPCI-UPCI卵巢癌孢子职业发展计划(CDP)的目的是支持卵巢癌转化性研究中年轻研究人员的职业发展。该计划的目标人群是杰出的入门级(即助理教授)科学和临床教师，但在某些情况下，可能包括具有独立研究职业生涯非凡潜力的高级博士后或临床研究员，或希望将其职业生涯重新集中在转化性卵巢癌研究上的知名研究人员。CDP的次要目标是通过鼓励从代表性不足的群体中招募优秀个人来促进卵巢癌研究人员的多样性。CDP将得到RPCI-UPCI卵巢癌孢子基金以及RPCI和UPCI配套的机构资金的支持。CDP作为一种结构化的机制，通过公开和竞争性的申请和审查过程来确定优秀的候选人，并将由此产生的获奖者与经验丰富的导师相匹配。CDP领导人将召集NIH格式研究小组，并将NIH R21类型的申请分配给两名科学家和一名患者倡导审查员。审查结果将在行政核心中汇总，并提交给内部咨询委员会，以便提出供资建议。成功的申请将获得每年50,000美元的资助，为期两年(总奖金为100,000美元)。根据资助年度的不同，我们预计每年资助三至五个奖项。CDP获奖者将被提供完全访问RPCI-UPCI卵巢癌孢子核心资源，包括组织标本和统计支持。CDP将通过以下方式直接促进职业发展：i)由在基础、临床和基于人口的研究方面具有专业知识的有才华的研究人员组成的RPCI-UPCI卵巢癌孢子执行委员会和内部咨询委员会进行建设性的提案审查，ii)从具有广泛学术生涯发展专业知识的不同教员中挑选一位导师进行研究培训，以及iii)获得发展/充实计划，包括卵巢癌现场研究小组会议、定期孢子会议、研讨会系列和RPCI-UPCi卵巢癌孢子年度务虚会。总之，CDP为RPCI和UPCI的下一代转化型卵巢癌研究人员的发展提供了重要的机制。

The purpose of the Career Developmental Program (CDP) of the RPCI-UPCI Ovarian Cancer SPORE is to support the career development of junior researchers in translational ovarian cancer research. The target population for the program is outstanding entry-level (i.e. Assistant Professor) scientific and clinical faculty, but in some cases may include senior postdoctoral or clinical fellows with exceptional potential for independent research careers, or established investigators wishing to refocus their careers on translational ovarian cancer research. A secondary goal of the CDP is to promote the diversity of ovarian cancer researchers, by encouraging the recruitment of outstanding individuals from underrepresented groups. The CDP will be supported both by RPCI-UPCI Ovarian Cancer SPORE funds and matching institutional funds from RPCI and UPCI. The CDP serves as a structured mechanism for identifying outstanding candidates through an open and competitive application and review process, and matching the resulting awardees with experienced mentors. The CDP Leaders will convene a NIH format study section and assign NIH R21-type applications to two scientific and one patient advocate reviewers. Review results will be summarized in the Administrative Core and submitted to the Internal Advisory Board for recommendations for funding. Successful applications will be funded at the level of $50,000 per year for of two years (total award $100,000). We anticipate to fund three to five awards per year depending on the funding year. CDP awardees will be provided full access to the RPCI-UPCI Ovarian Cancer SPORE Core resources, including tissue specimens and statistical support. The CDP will directly facilitate career development through: i) a constructive proposal review by the RPCI-UPCI Ovarian Cancer SPORE Executive Committee and Internal Advisory Board, which are composed of talented investigators with expertise in basic, clinical, and population-based research, ii) research training with a mentor chosen from among a diverse faculty with broad expertise in academic career development, and iii) access to development/enrichment programs, including ovarian cancer disease site research group meetings, periodic SPORE meetings, seminar series, and RPCI-UPCI Ovarian Cancer SPORE annual retreats. In summary, the CDP provides a vital mechanism for the development of the next generation of translational ovarian cancer researchers at RPCI and UPCI.